School of Medicine

Jeffrey I. Gordon, MD, director of the Center for Genome Sciences and Systems Biology, has been awarded the King Faisal International Prize in Medicine.

Highlighting a potential target in the treatment of multiple sclerosis (MS) and Alzheimer’s disease, new research suggests that triggering a protein found on the surface of brain cells may help slow the progression of these and other neurological diseases.

Mark J. Manary, MD, of Washington University School of Medicine in St. Louis, has been awarded one of three research grants from the Sackler Institute for Nutrition Science at the New York Academy of Sciences.

Marcus E. Raichle, MD, has been named an inaugural Alan A. and Edith L. Wolff Distinguished Professor of Medicine at the School of Medicine. A professor of radiology, psychology, biomedical engineering, neurobiology and neurology, his many honors include the 2014 Kavli Prize for Neuroscience.

Guided by the immune system, researchers have identified types of gut bacteria in both healthy and undernourished children in Malawi that are linked to nutritional health and that have diagnostic and therapeutic implications for childhood undernutrition.

Andrey Shaw, MD, the Emil R. Unanue Professor of Immunobiology in the Department of Pathology and Immunology and director of the Division of Immunobiology at Washington University School of Medicine in St. Louis, has received a one-year, $84,583 grant from the National Institutes of Health (NIH) and Confluence Life Sciences Inc. for research titled “Development of TAK1 Inhibitors to Treat Pancreatic Cancer.”

The next round of spring Assembly Series programs at Washington University in St. Louis will cover a variety of topics, from how society talks about contagious diseases to delving into major philosophical theory to the possibility of cloning a mammoth.

Studying zebrafish embryos, researchers at Washington University School of Medicine in St. Louis have shown that the epigenome plays a significant part in guiding development in the first 24 hours after fertilization. The research may deepen understanding of congenital defects and miscarriage.

​Applications for the Specialized Program of Research Excellence (SPORE) in Leukemia Career Enhancement and Developmental Research Awards are being accepted through May 1.

An investigational drug appears to cut the risk of severe asthma attacks in half for patients who have difficulty controlling the disorder with standard medications, according to results from two multicenter clinical trials headed by Mario Castro, MD, the Alan A. and Edith L. Wolff Professor of Pulmonary and Critical Care Medicine at the School of Medicine.